Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Alcresta Investment Reflects Omega Market Growth

This article was originally published in The Tan Sheet

Executive Summary

Alcresta is developing omega-3 and -6 fatty acid supplements that are more easily digested and absorbable. Founders Alexey Margolin and Robert Gallotto look to repeat the success they had in 2010 when they sold an earlier nutritionals start-up for $180 million.

Advertisement

Related Content

Industry Roundup: Health Care Capital, Mannatech Plans
DSM Makes Waves In Omega-3 Fish Oil With Ocean Nutrition Pick-Up
DSM Makes Waves In Omega-3 Fish Oil With Ocean Nutrition Pick-Up
In Brief
Will The Rising Tide Of Rx Omega-3s Float The Fish Oil Supplement Market?
On Q3 Earnings Call, Lilly Vows To Stay Its Current Course Despite Late-Stage Pipeline Setbacks

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS105701

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel